Pathway Health Corp. Reports Third Quarter 2022 Financial Results
- Adjusted EBITDA loss improved by 20% from previous quarter to $1.3 million compared to $1.7 million in the previous quarter
- Entered into a $3.5 million revolving line of credit to s…